La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Expleo Solutions Bilan de santé
Santé financière contrôle des critères 5/6
Expleo Solutions has a total shareholder equity of ₹6.1B and total debt of ₹260.6M, which brings its debt-to-equity ratio to 4.3%. Its total assets and total liabilities are ₹7.6B and ₹1.5B respectively. Expleo Solutions's EBIT is ₹1.2B making its interest coverage ratio 44.5. It has cash and short-term investments of ₹2.0B.
Informations clés
4.3%
Ratio d'endettement
₹260.56m
Dette
Ratio de couverture des intérêts | 44.5x |
Argent liquide | ₹1.99b |
Fonds propres | ₹6.11b |
Total du passif | ₹1.54b |
Total des actifs | ₹7.65b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?
Jun 21Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital
Mar 15The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence
Sep 15Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now
Aug 19Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Jul 14Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital
May 05A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Mar 15Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?
Feb 15Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital
Jan 24Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year
Jan 04A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Dec 14Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?
Nov 26Analyse de la situation financière
Passif à court terme: EXPLEOSOL's short term assets (₹6.0B) exceed its short term liabilities (₹1.0B).
Passif à long terme: EXPLEOSOL's short term assets (₹6.0B) exceed its long term liabilities (₹499.8M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: EXPLEOSOL has more cash than its total debt.
Réduire la dette: EXPLEOSOL's debt to equity ratio has increased from 0% to 4.3% over the past 5 years.
Couverture de la dette: EXPLEOSOL's debt is well covered by operating cash flow (265.6%).
Couverture des intérêts: EXPLEOSOL's interest payments on its debt are well covered by EBIT (44.5x coverage).